| 0 |
BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS |
11 |
0.8462 |
| 1 |
ANTI FACTOR V ANTIBODY |
19 |
0.6786 |
| 2 |
WEISSELLA INFECTION |
7 |
0.6364 |
| 3 |
PRE-ENGRAFTMENT IMMUNE REACTION |
44 |
0.5500 |
| 4 |
PULMONARY TRICHOSPORONOSIS |
8 |
0.3478 |
| 5 |
PROTOTHECOSIS |
26 |
0.2766 |
| 6 |
GEOTRICHUM INFECTION |
51 |
0.2417 |
| 7 |
AORTOENTERIC FISTULA |
13 |
0.2031 |
| 8 |
CORYNEBACTERIUM BACTERAEMIA |
17 |
0.2000 |
| 9 |
GASTROINTESTINAL MUCORMYCOSIS |
25 |
0.1497 |
| 10 |
CEREBRAL VENTRICLE COLLAPSE |
10 |
0.1333 |
| 11 |
TRICHOSPORON INFECTION |
46 |
0.1136 |
| 12 |
FUNGAL ENDOCARDITIS |
34 |
0.1130 |
| 13 |
DISSEMINATED MUCORMYCOSIS |
44 |
0.1117 |
| 14 |
MYCOTIC ENDOPHTHALMITIS |
21 |
0.1111 |
| 15 |
INTRACRANIAL INFECTION |
13 |
0.1040 |
| 16 |
SEPTAL PANNICULITIS |
8 |
0.1000 |
| 17 |
PULMONARY MUCORMYCOSIS |
52 |
0.0985 |
| 18 |
FUSARIUM INFECTION |
68 |
0.0971 |
| 19 |
FLUOROSIS |
8 |
0.0930 |
| 20 |
MENINGITIS ENTEROCOCCAL |
7 |
0.0886 |
| 21 |
HEPATIC CANDIDIASIS |
6 |
0.0882 |
| 22 |
ADRENERGIC SYNDROME |
7 |
0.0864 |
| 23 |
SCEDOSPORIUM INFECTION |
60 |
0.0850 |
| 24 |
ENDOCARDITIS CANDIDA |
6 |
0.0789 |
| 25 |
BLOOD BETA-D-GLUCAN INCREASED |
24 |
0.0782 |
| 26 |
PERIOSTITIS |
31 |
0.0718 |
| 27 |
ENGRAFT FAILURE |
20 |
0.0697 |
| 28 |
GRAFT VERSUS HOST DISEASE IN INTESTINE |
9 |
0.0692 |
| 29 |
HEPATOSPLENIC CANDIDIASIS |
10 |
0.0680 |
| 30 |
FUNGAEMIA |
107 |
0.0679 |
| 31 |
HAEMORRHAGIC NECROTIC PANCREATITIS |
5 |
0.0667 |
| 32 |
CEREBRAL ASPERGILLOSIS |
40 |
0.0650 |
| 33 |
RHINOCEREBRAL MUCORMYCOSIS |
21 |
0.0605 |
| 34 |
NASAL FLARING |
8 |
0.0593 |
| 35 |
BILOMA |
8 |
0.0567 |
| 36 |
ENCEPHALITIS FUNGAL |
5 |
0.0556 |
| 37 |
DISSEMINATED ASPERGILLOSIS |
26 |
0.0551 |
| 38 |
CYSTITIS VIRAL |
21 |
0.0548 |
| 39 |
CRYPTOCOCCAL MENINGOENCEPHALITIS |
7 |
0.0534 |
| 40 |
SYSTEMIC MYCOSIS |
61 |
0.0522 |
| 41 |
SYSTEMIC CANDIDA |
130 |
0.0517 |
| 42 |
IDIOPATHIC PNEUMONIA SYNDROME |
15 |
0.0503 |
| 43 |
FUNGAL DISEASE CARRIER |
5 |
0.0495 |
| 44 |
CANDIDA ENDOPHTHALMITIS |
6 |
0.0492 |
| 45 |
HAEMOSTASIS |
8 |
0.0491 |
| 46 |
ASPERGILLUS TEST POSITIVE |
15 |
0.0487 |
| 47 |
BURKHOLDERIA TEST POSITIVE |
6 |
0.0484 |
| 48 |
MUCORMYCOSIS |
125 |
0.0481 |
| 49 |
NASAL ABSCESS |
11 |
0.0476 |
| 50 |
GASTROINTESTINAL FUNGAL INFECTION |
24 |
0.0466 |
| 51 |
HYPEROXALURIA |
8 |
0.0465 |
| 52 |
SEPTIC PULMONARY EMBOLISM |
9 |
0.0462 |
| 53 |
HUMAN HERPESVIRUS 6 ENCEPHALITIS |
13 |
0.0458 |
| 54 |
LYMPHOID TISSUE HYPOPLASIA |
7 |
0.0458 |
| 55 |
ENTEROCOCCAL SEPSIS |
37 |
0.0457 |
| 56 |
ENCEPHALITIS VIRAL |
55 |
0.0452 |
| 57 |
PHAEHYPHOMYCOSIS |
6 |
0.0448 |
| 58 |
STENOTROPHOMONAS TEST POSITIVE |
6 |
0.0448 |
| 59 |
ABDOMINAL WOUND DEHISCENCE |
12 |
0.0440 |
| 60 |
CUTANEOUS MUCORMYCOSIS |
8 |
0.0435 |
| 61 |
ADENOVIRAL HAEMORRHAGIC CYSTITIS |
9 |
0.0433 |
| 62 |
CENTRAL NERVOUS SYSTEM FUNGAL INFECTION |
10 |
0.0431 |
| 63 |
ADENOVIRAL HEPATITIS |
10 |
0.0426 |
| 64 |
THYMUS HYPOPLASIA |
7 |
0.0402 |
| 65 |
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE |
56 |
0.0396 |
| 66 |
ACUTE GRAFT VERSUS HOST DISEASE IN LIVER |
28 |
0.0389 |
| 67 |
CEREBRAL FUNGAL INFECTION |
11 |
0.0389 |
| 68 |
BACTERIAL TOXAEMIA |
5 |
0.0388 |
| 69 |
CANDIDA TEST POSITIVE |
16 |
0.0383 |
| 70 |
MORGANELLA INFECTION |
11 |
0.0375 |
| 71 |
CITROBACTER INFECTION |
16 |
0.0373 |
| 72 |
LACTOBACILLUS INFECTION |
6 |
0.0366 |
| 73 |
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN |
100 |
0.0361 |
| 74 |
HUMAN HERPESVIRUS 6 INFECTION |
66 |
0.0349 |
| 75 |
EYE INFECTION FUNGAL |
13 |
0.0336 |
| 76 |
ALLERGIC TRANSFUSION REACTION |
5 |
0.0331 |
| 77 |
ANTITHROMBIN III DECREASED |
9 |
0.0330 |
| 78 |
CYTOMEGALOVIRUS TEST POSITIVE |
58 |
0.0325 |
| 79 |
GRAFT VERSUS HOST DISEASE IN LIVER |
23 |
0.0321 |
| 80 |
ALLOGENIC STEM CELL TRANSPLANTATION |
5 |
0.0316 |
| 81 |
HEPATIC VEIN OCCLUSION |
5 |
0.0316 |
| 82 |
BACTERIAL TRANSLOCATION |
10 |
0.0315 |
| 83 |
ASPERGILLUS INFECTION |
205 |
0.0312 |
| 84 |
SINUSITIS FUNGAL |
25 |
0.0312 |
| 85 |
PARENTERAL NUTRITION |
7 |
0.0303 |
| 86 |
OSTEOMYELITIS FUNGAL |
5 |
0.0299 |
| 87 |
CHRONIC GRAFT VERSUS HOST DISEASE IN LUNG |
5 |
0.0289 |
| 88 |
ABSCESS FUNGAL |
5 |
0.0286 |
| 89 |
PLASMA CELL LEUKAEMIA |
17 |
0.0283 |
| 90 |
INFECTIVE ANEURYSM |
14 |
0.0283 |
| 91 |
BRONCHOPULMONARY ASPERGILLOSIS |
215 |
0.0277 |
| 92 |
ENGRAFTMENT SYNDROME |
16 |
0.0271 |
| 93 |
MENINGOENCEPHALITIS HERPETIC |
12 |
0.0268 |
| 94 |
STAPHYLOCOCCAL SCALDED SKIN SYNDROME |
6 |
0.0267 |
| 95 |
DISSEMINATED CRYPTOCOCCOSIS |
20 |
0.0264 |
| 96 |
NECROTISING OESOPHAGITIS |
13 |
0.0261 |
| 97 |
SINUS POLYP |
15 |
0.0260 |
| 98 |
GASTROINTESTINAL MUCOSAL DISORDER |
17 |
0.0260 |
| 99 |
FACTOR V INHIBITION |
5 |
0.0258 |
| 100 |
ACUTE MYELOID LEUKAEMIA RECURRENT |
55 |
0.0256 |
| 101 |
ENTEROCOCCAL INFECTION |
123 |
0.0254 |
| 102 |
VIRAL HAEMORRHAGIC CYSTITIS |
18 |
0.0253 |
| 103 |
PYROGLUTAMIC ACIDOSIS |
10 |
0.0252 |
| 104 |
PNEUMONIA FUNGAL |
98 |
0.0248 |
| 105 |
ENCEPHALITIS HERPES |
12 |
0.0243 |
| 106 |
KLEBSIELLA BACTERAEMIA |
23 |
0.0242 |
| 107 |
ALTERNARIA INFECTION |
9 |
0.0242 |
| 108 |
RECTAL PERFORATION |
13 |
0.0241 |
| 109 |
ACUTE PROMYELOCYTIC LEUKAEMIA DIFFERENTIATION SYNDROME |
5 |
0.0240 |
| 110 |
DELAYED GRAFT FUNCTION |
17 |
0.0239 |
| 111 |
GLOMERULOSCLEROSIS |
15 |
0.0237 |
| 112 |
INFECTION IN AN IMMUNOCOMPROMISED HOST |
17 |
0.0237 |
| 113 |
STENOTROPHOMONAS INFECTION |
32 |
0.0236 |
| 114 |
ZYGOMYCOSIS |
11 |
0.0235 |
| 115 |
BRAIN ABSCESS |
58 |
0.0229 |
| 116 |
ENTEROCOCCAL BACTERAEMIA |
24 |
0.0226 |
| 117 |
HUMAN POLYOMAVIRUS INFECTION |
12 |
0.0226 |
| 118 |
ANTIBIOTIC LEVEL ABOVE THERAPEUTIC |
9 |
0.0222 |
| 119 |
CYTOMEGALOVIRUS ENTEROCOLITIS |
17 |
0.0221 |
| 120 |
PRIMARY MYELOFIBROSIS |
7 |
0.0217 |
| 121 |
FUNGAL SEPSIS |
18 |
0.0217 |
| 122 |
ENTEROCOCCUS TEST POSITIVE |
14 |
0.0216 |
| 123 |
HERPES SIMPLEX HEPATITIS |
5 |
0.0209 |
| 124 |
OPHTHALMIC VEIN THROMBOSIS |
5 |
0.0207 |
| 125 |
CARDIAC VALVE VEGETATION |
10 |
0.0206 |
| 126 |
PULMONARY MYCOSIS |
16 |
0.0205 |
| 127 |
ACUTE GRAFT VERSUS HOST DISEASE |
94 |
0.0205 |
| 128 |
ASPARTATE AMINOTRANSFERASE |
5 |
0.0205 |
| 129 |
ECTHYMA |
8 |
0.0200 |
| 130 |
MUCOSAL EROSION |
18 |
0.0198 |
| 131 |
TRACHEOBRONCHITIS |
15 |
0.0195 |
| 132 |
BRONCHIAL HAEMORRHAGE |
6 |
0.0192 |
| 133 |
MYCOPLASMA INFECTION |
15 |
0.0192 |
| 134 |
CRYPTOSPORIDIOSIS INFECTION |
10 |
0.0190 |
| 135 |
CANDIDA SEPSIS |
17 |
0.0190 |
| 136 |
DEVICE RELATED SEPSIS |
38 |
0.0189 |
| 137 |
PSEUDOMONAL SEPSIS |
33 |
0.0188 |
| 138 |
REACTIVE GASTROPATHY |
7 |
0.0183 |
| 139 |
BACTERIAL SEPSIS |
57 |
0.0175 |
| 140 |
MEDIASTINITIS |
10 |
0.0172 |
| 141 |
GRAFT VERSUS HOST DISEASE IN SKIN |
38 |
0.0172 |
| 142 |
DYSBIOSIS |
14 |
0.0171 |
| 143 |
FUNGAL OESOPHAGITIS |
12 |
0.0170 |
| 144 |
SEPTIC EMBOLUS |
14 |
0.0168 |
| 145 |
CORYNEBACTERIUM INFECTION |
9 |
0.0168 |
| 146 |
GRAFT VERSUS HOST DISEASE IN LUNG |
8 |
0.0167 |
| 147 |
INFECTIOUS PLEURAL EFFUSION |
25 |
0.0164 |
| 148 |
DIFFERENTIATION SYNDROME |
12 |
0.0163 |
| 149 |
LINEAR IGA DISEASE |
27 |
0.0162 |
| 150 |
BACTERIURIA |
9 |
0.0159 |
| 151 |
KLEBSIELLA INFECTION |
77 |
0.0152 |
| 152 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
431 |
0.0152 |
| 153 |
STAPHYLOCOCCAL BACTERAEMIA |
66 |
0.0152 |
| 154 |
VENOOCCLUSIVE LIVER DISEASE |
74 |
0.0150 |
| 155 |
HYPOPERFUSION |
15 |
0.0143 |
| 156 |
CYTOMEGALOVIRUS HEPATITIS |
5 |
0.0141 |
| 157 |
CANDIDA INFECTION |
237 |
0.0140 |
| 158 |
CHRONIC GRAFT VERSUS HOST DISEASE |
49 |
0.0136 |
| 159 |
CYTOMEGALOVIRUS VIRAEMIA |
60 |
0.0135 |
| 160 |
INTENSIVE CARE UNIT ACQUIRED WEAKNESS |
5 |
0.0132 |
| 161 |
IMMUNOSUPPRESSANT DRUG LEVEL INCREASED |
43 |
0.0130 |
| 162 |
PSEUDOMONAL BACTERAEMIA |
11 |
0.0129 |
| 163 |
LOWER RESPIRATORY TRACT INFECTION FUNGAL |
5 |
0.0129 |
| 164 |
HAEMORRHAGIC INFARCTION |
7 |
0.0128 |
| 165 |
GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT |
27 |
0.0127 |
| 166 |
ENTEROBACTER INFECTION |
21 |
0.0125 |
| 167 |
CAT SCRATCH DISEASE |
5 |
0.0124 |
| 168 |
ASPERGILLOSIS |
16 |
0.0122 |
| 169 |
GRAFT VERSUS HOST DISEASE |
87 |
0.0121 |
| 170 |
PNEUMONIA KLEBSIELLA |
22 |
0.0120 |
| 171 |
HYPOGONADISM |
12 |
0.0119 |
| 172 |
PATHOGEN RESISTANCE |
107 |
0.0117 |
| 173 |
ESCHERICHIA SEPSIS |
34 |
0.0117 |
| 174 |
ENTEROVIRUS INFECTION |
10 |
0.0116 |
| 175 |
HYPHAEMA |
6 |
0.0115 |
| 176 |
PULMONARY CAVITATION |
10 |
0.0115 |
| 177 |
CHOLESTATIC LIVER INJURY |
25 |
0.0112 |
| 178 |
OESOPHAGEAL INFECTION |
5 |
0.0112 |
| 179 |
NEUTROPENIC COLITIS |
23 |
0.0111 |
| 180 |
ESCHERICHIA BACTERAEMIA |
26 |
0.0110 |
| 181 |
ACINETOBACTER INFECTION |
12 |
0.0110 |
| 182 |
BOTULISM |
9 |
0.0109 |
| 183 |
CHORIORETINITIS |
7 |
0.0109 |
| 184 |
LIVER ABSCESS |
35 |
0.0108 |
| 185 |
HAEMATOLOGICAL INFECTION |
26 |
0.0106 |
| 186 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
79 |
0.0105 |
| 187 |
NEUTROPENIC INFECTION |
10 |
0.0104 |
| 188 |
BLASTOMYCOSIS |
5 |
0.0103 |
| 189 |
HAEMOPHILUS INFECTION |
10 |
0.0102 |
| 190 |
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER |
18 |
0.0102 |
| 191 |
LUNG CONSOLIDATION |
28 |
0.0100 |
| 192 |
METABOLIC ALKALOSIS |
16 |
0.0100 |
| 193 |
CYSTITIS HAEMORRHAGIC |
40 |
0.0099 |
| 194 |
OBLITERATIVE BRONCHIOLITIS |
13 |
0.0099 |
| 195 |
PNEUMONIA PSEUDOMONAL |
15 |
0.0098 |
| 196 |
PROTEUS INFECTION |
7 |
0.0097 |
| 197 |
VASOGENIC CEREBRAL OEDEMA |
7 |
0.0097 |
| 198 |
CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN |
9 |
0.0097 |
| 199 |
CENTRAL NERVOUS SYSTEM INFECTION |
11 |
0.0096 |
| 200 |
DISSEMINATED INTRAVASCULAR COAGULATION |
135 |
0.0096 |
| 201 |
BACILLUS INFECTION |
6 |
0.0095 |
| 202 |
MYCOBACTERIUM CHELONAE INFECTION |
7 |
0.0095 |
| 203 |
POLYOMAVIRUS VIRAEMIA |
10 |
0.0094 |
| 204 |
STAPHYLOCOCCAL SEPSIS |
46 |
0.0093 |
| 205 |
ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT |
24 |
0.0093 |
| 206 |
PNEUMONIA NECROTISING |
6 |
0.0093 |
| 207 |
VASCULAR DEVICE INFECTION |
42 |
0.0092 |
| 208 |
KLEBSIELLA TEST POSITIVE |
6 |
0.0092 |
| 209 |
CRYSTALLURIA |
5 |
0.0092 |
| 210 |
LUNG TRANSPLANT REJECTION |
6 |
0.0091 |
| 211 |
EMPYEMA |
18 |
0.0090 |
| 212 |
ADENOVIRUS INFECTION |
26 |
0.0090 |
| 213 |
PSEUDOMEMBRANOUS COLITIS |
20 |
0.0089 |
| 214 |
METAPNEUMOVIRUS INFECTION |
7 |
0.0089 |
| 215 |
BLOOD FIBRINOGEN INCREASED |
7 |
0.0089 |
| 216 |
COLONIC FISTULA |
5 |
0.0088 |
| 217 |
VENOOCCLUSIVE DISEASE |
22 |
0.0088 |
| 218 |
DIFFUSE ALVEOLAR DAMAGE |
10 |
0.0087 |
| 219 |
PERFORATION |
7 |
0.0087 |
| 220 |
BACTERAEMIA |
103 |
0.0087 |
| 221 |
KIDNEY FIBROSIS |
15 |
0.0086 |
| 222 |
BLAST CELL COUNT INCREASED |
9 |
0.0086 |
| 223 |
RENAL ABSCESS |
7 |
0.0085 |
| 224 |
MALIGNANT PERITONEAL NEOPLASM |
5 |
0.0085 |
| 225 |
TOXOPLASMOSIS |
9 |
0.0083 |
| 226 |
IMMUNOSUPPRESSANT DRUG LEVEL DECREASED |
10 |
0.0083 |
| 227 |
STREPTOCOCCAL BACTERAEMIA |
9 |
0.0083 |
| 228 |
SEPTIC SHOCK |
356 |
0.0082 |
| 229 |
TRANSPLANT FAILURE |
20 |
0.0081 |
| 230 |
IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME |
48 |
0.0081 |
| 231 |
MUCOUS MEMBRANE DISORDER |
11 |
0.0080 |
| 232 |
BRAIN HERNIATION |
24 |
0.0080 |
| 233 |
RHINOVIRUS INFECTION |
31 |
0.0080 |
| 234 |
EPSTEIN-BARR VIRUS TEST POSITIVE |
5 |
0.0079 |
| 235 |
SPINAL CORD DISORDER |
13 |
0.0079 |
| 236 |
ABDOMINAL COMPARTMENT SYNDROME |
5 |
0.0078 |
| 237 |
HAEMODYNAMIC INSTABILITY |
59 |
0.0077 |
| 238 |
VARICELLA ZOSTER VIRUS INFECTION |
16 |
0.0077 |
| 239 |
HYPERMAGNESAEMIA |
5 |
0.0077 |
| 240 |
ENDOCARDITIS BACTERIAL |
6 |
0.0076 |
| 241 |
ILEAL PERFORATION |
5 |
0.0075 |
| 242 |
THROMBOTIC MICROANGIOPATHY |
73 |
0.0075 |
| 243 |
SMALL INTESTINAL HAEMORRHAGE |
15 |
0.0074 |
| 244 |
MENINGITIS CRYPTOCOCCAL |
13 |
0.0074 |
| 245 |
BK VIRUS INFECTION |
25 |
0.0074 |
| 246 |
HISTIOCYTOSIS HAEMATOPHAGIC |
22 |
0.0074 |
| 247 |
BLOOD CULTURE POSITIVE |
22 |
0.0073 |
| 248 |
CYTOMEGALOVIRUS INFECTION |
122 |
0.0073 |
| 249 |
ISCHAEMIC HEPATITIS |
10 |
0.0073 |
| 250 |
FEBRILE NEUTROPENIA |
482 |
0.0073 |
| 251 |
CYTOKINE RELEASE SYNDROME |
143 |
0.0071 |
| 252 |
ENTHESOPATHY |
11 |
0.0070 |
| 253 |
ACUTE SINUSITIS |
12 |
0.0070 |
| 254 |
ORAL FUNGAL INFECTION |
19 |
0.0069 |
| 255 |
FUNGAL SKIN INFECTION |
28 |
0.0069 |
| 256 |
INCISION SITE PAIN |
8 |
0.0068 |
| 257 |
CLOSTRIDIUM TEST POSITIVE |
15 |
0.0068 |
| 258 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
18 |
0.0068 |
| 259 |
RESPIRATORY ALKALOSIS |
11 |
0.0068 |
| 260 |
CRYPTOCOCCOSIS |
11 |
0.0067 |
| 261 |
SKIN NECROSIS |
35 |
0.0067 |
| 262 |
SECONDARY IMMUNODEFICIENCY |
8 |
0.0066 |
| 263 |
PARAINFLUENZAE VIRUS INFECTION |
10 |
0.0066 |
| 264 |
CELL DEATH |
13 |
0.0065 |
| 265 |
WOUND DEHISCENCE |
22 |
0.0065 |
| 266 |
LEUKAEMIA RECURRENT |
11 |
0.0065 |
| 267 |
DRUG RESISTANCE |
166 |
0.0065 |
| 268 |
HYPOALBUMINAEMIA |
50 |
0.0064 |
| 269 |
HYPERBILIRUBINAEMIA |
66 |
0.0064 |
| 270 |
MEGACOLON |
10 |
0.0064 |
| 271 |
ATYPICAL MYCOBACTERIAL INFECTION |
9 |
0.0064 |
| 272 |
FUNCTIONAL GASTROINTESTINAL DISORDER |
22 |
0.0064 |
| 273 |
RESPIRATORY ACIDOSIS |
25 |
0.0064 |
| 274 |
DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY |
6 |
0.0063 |
| 275 |
HYPERURICAEMIA |
26 |
0.0063 |
| 276 |
APLASTIC ANAEMIA |
33 |
0.0063 |
| 277 |
EPSTEIN-BARR VIRAEMIA |
7 |
0.0063 |
| 278 |
MENINGITIS BACTERIAL |
9 |
0.0063 |
| 279 |
CAPILLARY LEAK SYNDROME |
13 |
0.0063 |
| 280 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
24 |
0.0063 |
| 281 |
KLEBSIELLA SEPSIS |
7 |
0.0062 |
| 282 |
RED BLOOD CELLS URINE POSITIVE |
6 |
0.0062 |
| 283 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
108 |
0.0061 |
| 284 |
FUNGAL PERITONITIS |
9 |
0.0059 |
| 285 |
STREPTOCOCCAL SEPSIS |
7 |
0.0059 |
| 286 |
ENTERITIS INFECTIOUS |
10 |
0.0059 |
| 287 |
TUMOUR LYSIS SYNDROME |
51 |
0.0058 |
| 288 |
NEPHROPATHY TOXIC |
65 |
0.0058 |
| 289 |
HYPOGAMMAGLOBULINAEMIA |
38 |
0.0058 |
| 290 |
VIRAEMIA |
8 |
0.0058 |
| 291 |
PERITONEAL HAEMORRHAGE |
8 |
0.0058 |
| 292 |
PSEUDOMONAS INFECTION |
49 |
0.0057 |
| 293 |
ENTEROCUTANEOUS FISTULA |
5 |
0.0057 |
| 294 |
IMPRISONMENT |
10 |
0.0057 |
| 295 |
ACUTE LYMPHOCYTIC LEUKAEMIA |
16 |
0.0056 |
| 296 |
HYPERLEUKOCYTOSIS |
5 |
0.0056 |
| 297 |
ACUTE FEBRILE NEUTROPHILIC DERMATOSIS |
13 |
0.0056 |
| 298 |
BILIRUBIN CONJUGATED INCREASED |
13 |
0.0056 |
| 299 |
ORGAN FAILURE |
22 |
0.0055 |
| 300 |
INTRA-ABDOMINAL HAEMORRHAGE |
13 |
0.0055 |
| 301 |
SHOCK HAEMORRHAGIC |
44 |
0.0054 |
| 302 |
SUSPECTED OFF LABEL USE |
24 |
0.0053 |
| 303 |
VITH NERVE PARALYSIS |
6 |
0.0053 |
| 304 |
TRANSPLANT REJECTION |
42 |
0.0052 |
| 305 |
HYPERTRANSAMINASAEMIA |
36 |
0.0052 |
| 306 |
PULMONARY ALVEOLAR HAEMORRHAGE |
29 |
0.0052 |
| 307 |
MULTI-ORGAN DISORDER |
10 |
0.0051 |
| 308 |
CEREBRAL HAEMATOMA |
17 |
0.0051 |
| 309 |
HYPOFIBRINOGENAEMIA |
5 |
0.0050 |
| 310 |
HEPATIC NECROSIS |
19 |
0.0050 |
| 311 |
FUNGAL INFECTION |
168 |
0.0050 |
| 312 |
SERUM SICKNESS |
14 |
0.0050 |
| 313 |
ESCHERICHIA TEST POSITIVE |
6 |
0.0050 |
| 314 |
ACUTE MYELOID LEUKAEMIA |
78 |
0.0050 |
| 315 |
PNEUMOMEDIASTINUM |
9 |
0.0050 |
| 316 |
HYPOCHROMIC ANAEMIA |
5 |
0.0049 |
| 317 |
LUNG OPACITY |
13 |
0.0049 |
| 318 |
MULTI-ORGAN FAILURE |
84 |
0.0049 |
| 319 |
BLOOD UREA DECREASED |
6 |
0.0048 |
| 320 |
PULMONARY SEPSIS |
7 |
0.0048 |
| 321 |
LUNG ABSCESS |
10 |
0.0048 |
| 322 |
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER |
24 |
0.0047 |
| 323 |
TOXIC EPIDERMAL NECROLYSIS |
71 |
0.0047 |
| 324 |
PLATELET TRANSFUSION |
6 |
0.0047 |
| 325 |
EPSTEIN-BARR VIRUS INFECTION |
29 |
0.0046 |
| 326 |
CONCOMITANT DISEASE PROGRESSION |
9 |
0.0046 |
| 327 |
APLASIA |
9 |
0.0046 |
| 328 |
EPSTEIN-BARR VIRUS INFECTION REACTIVATION |
6 |
0.0046 |
| 329 |
PULSELESS ELECTRICAL ACTIVITY |
19 |
0.0045 |
| 330 |
THROMBOTIC THROMBOCYTOPENIC PURPURA |
16 |
0.0045 |
| 331 |
CATHETER SITE INFECTION |
17 |
0.0045 |
| 332 |
PARESIS |
10 |
0.0045 |
| 333 |
HYPERLACTACIDAEMIA |
12 |
0.0045 |
| 334 |
PULMONARY HAEMORRHAGE |
35 |
0.0045 |
| 335 |
HISTOPLASMOSIS DISSEMINATED |
7 |
0.0044 |
| 336 |
COVID-19 PNEUMONIA |
52 |
0.0044 |
| 337 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
44 |
0.0044 |
| 338 |
NEUROLOGICAL SYMPTOM |
25 |
0.0044 |
| 339 |
INFECTION REACTIVATION |
5 |
0.0044 |
| 340 |
PNEUMONIA BACTERIAL |
40 |
0.0044 |
| 341 |
URINARY TRACT INFECTION BACTERIAL |
11 |
0.0043 |
| 342 |
CYTOMEGALOVIRUS COLITIS |
10 |
0.0043 |
| 343 |
NEPHROGENIC DIABETES INSIPIDUS |
5 |
0.0043 |
| 344 |
RESPIRATORY FAILURE |
308 |
0.0042 |
| 345 |
HYPERNATRAEMIA |
21 |
0.0042 |
| 346 |
DRUG LEVEL BELOW THERAPEUTIC |
23 |
0.0042 |
| 347 |
PNEUMONIA CYTOMEGALOVIRAL |
8 |
0.0041 |
| 348 |
CYTOMEGALOVIRUS CHORIORETINITIS |
8 |
0.0041 |
| 349 |
MONOCYTE COUNT DECREASED |
5 |
0.0041 |
| 350 |
BACTERIAL INFECTION |
76 |
0.0041 |
| 351 |
PNEUMONIA STAPHYLOCOCCAL |
8 |
0.0041 |
| 352 |
ACUTE PSYCHOSIS |
10 |
0.0040 |
| 353 |
BACTERIAL TEST POSITIVE |
9 |
0.0040 |
| 354 |
OLIGURIA |
25 |
0.0040 |
| 355 |
ACUTE RESPIRATORY FAILURE |
77 |
0.0040 |
| 356 |
INTESTINAL ISCHAEMIA |
22 |
0.0040 |
| 357 |
MIXED LIVER INJURY |
12 |
0.0040 |
| 358 |
HYPERCAPNIA |
12 |
0.0040 |
| 359 |
LIVER TRANSPLANT REJECTION |
7 |
0.0039 |
| 360 |
CLOSTRIDIUM DIFFICILE COLITIS |
41 |
0.0039 |
| 361 |
SEPSIS |
427 |
0.0038 |
| 362 |
NON-HODGKIN'S LYMPHOMA |
5 |
0.0038 |
| 363 |
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME |
19 |
0.0038 |
| 364 |
GASTROENTERITIS NOROVIRUS |
5 |
0.0038 |
| 365 |
ADENOCARCINOMA OF COLON |
7 |
0.0037 |
| 366 |
MYCOBACTERIUM AVIUM COMPLEX INFECTION |
10 |
0.0037 |
| 367 |
BRAIN OEDEMA |
47 |
0.0037 |
| 368 |
STRONGYLOIDIASIS |
6 |
0.0037 |
| 369 |
INTERVERTEBRAL DISCITIS |
7 |
0.0037 |
| 370 |
DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT |
8 |
0.0036 |
| 371 |
BILIARY TRACT DISORDER |
5 |
0.0036 |
| 372 |
RASH MORBILLIFORM |
10 |
0.0036 |
| 373 |
SERUM FERRITIN INCREASED |
19 |
0.0036 |
| 374 |
DEVICE RELATED INFECTION |
55 |
0.0036 |
| 375 |
MUCOSAL INFLAMMATION |
93 |
0.0035 |
| 376 |
MULTIPLE-DRUG RESISTANCE |
11 |
0.0035 |
| 377 |
GASTROINTESTINAL TOXICITY |
17 |
0.0035 |
| 378 |
ABDOMINAL INFECTION |
9 |
0.0035 |
| 379 |
ENDOCARDITIS |
18 |
0.0035 |
| 380 |
MYCOBACTERIAL INFECTION |
6 |
0.0035 |
| 381 |
NEUROLOGICAL DECOMPENSATION |
8 |
0.0035 |
| 382 |
LABELLED DRUG-DRUG INTERACTION ISSUE |
5 |
0.0035 |
| 383 |
PANCYTOPENIA |
192 |
0.0034 |
| 384 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
15 |
0.0034 |
| 385 |
STAPHYLOCOCCUS TEST POSITIVE |
7 |
0.0033 |
| 386 |
TORSADE DE POINTES |
26 |
0.0033 |
| 387 |
HYDROCEPHALUS |
18 |
0.0033 |
| 388 |
HYPOXIA |
116 |
0.0033 |
| 389 |
ESCHERICHIA INFECTION |
27 |
0.0033 |
| 390 |
MEAN CELL HAEMOGLOBIN DECREASED |
6 |
0.0033 |
| 391 |
ORAL DISORDER |
24 |
0.0033 |
| 392 |
HYPERPHOSPHATAEMIA |
7 |
0.0033 |
| 393 |
MEAN CELL VOLUME DECREASED |
5 |
0.0032 |
| 394 |
GRANULOCYTE COUNT DECREASED |
6 |
0.0032 |
| 395 |
MYELITIS |
5 |
0.0032 |
| 396 |
INTRAVENTRICULAR HAEMORRHAGE |
8 |
0.0032 |
| 397 |
ENDOTRACHEAL INTUBATION |
9 |
0.0032 |
| 398 |
ATELECTASIS |
31 |
0.0032 |
| 399 |
BLOOD CREATININE DECREASED |
10 |
0.0032 |
| 400 |
COAGULOPATHY |
53 |
0.0032 |
| 401 |
LARGE INTESTINE PERFORATION |
22 |
0.0032 |
| 402 |
ABDOMINAL ABSCESS |
14 |
0.0032 |
| 403 |
RETROPERITONEAL HAEMATOMA |
7 |
0.0032 |
| 404 |
OESOPHAGEAL STENOSIS |
9 |
0.0032 |
| 405 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
16 |
0.0032 |
| 406 |
BLOOD ALBUMIN DECREASED |
25 |
0.0031 |
| 407 |
SPINAL STENOSIS |
13 |
0.0031 |
| 408 |
ACIDOSIS |
24 |
0.0031 |
| 409 |
ANURIA |
27 |
0.0031 |
| 410 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
19 |
0.0031 |
| 411 |
DISSEMINATED TUBERCULOSIS |
8 |
0.0031 |
| 412 |
BLOOD UREA INCREASED |
52 |
0.0031 |
| 413 |
CYTOPENIA |
38 |
0.0031 |
| 414 |
GASTROINTESTINAL NECROSIS |
9 |
0.0031 |
| 415 |
SHOCK |
71 |
0.0031 |
| 416 |
BLOOD BILIRUBIN INCREASED |
83 |
0.0031 |
| 417 |
STEVENS-JOHNSON SYNDROME |
68 |
0.0031 |
| 418 |
GENE MUTATION |
6 |
0.0030 |
| 419 |
ORGANISING PNEUMONIA |
15 |
0.0030 |
| 420 |
HAEMOLYTIC URAEMIC SYNDROME |
7 |
0.0030 |
| 421 |
CANDIDIASIS |
12 |
0.0030 |
| 422 |
WOUND HAEMORRHAGE |
11 |
0.0030 |
| 423 |
HEPATIC FUNCTION ABNORMAL |
111 |
0.0030 |
| 424 |
HYPOKALAEMIA |
136 |
0.0029 |
| 425 |
TACHYPNOEA |
40 |
0.0029 |
| 426 |
STAPHYLOCOCCAL INFECTION |
97 |
0.0029 |
| 427 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
28 |
0.0029 |
| 428 |
DIABETES INSIPIDUS |
7 |
0.0029 |
| 429 |
ENCEPHALITIS |
20 |
0.0029 |
| 430 |
MYELOSUPPRESSION |
103 |
0.0029 |
| 431 |
PLEURAL EFFUSION |
171 |
0.0028 |
| 432 |
PURULENT DISCHARGE |
12 |
0.0028 |
| 433 |
MONOPARESIS |
5 |
0.0028 |
| 434 |
PULMONARY MASS |
41 |
0.0027 |
| 435 |
DRUG LEVEL DECREASED |
28 |
0.0027 |
| 436 |
GENERALISED OEDEMA |
34 |
0.0027 |
| 437 |
LYMPHOPROLIFERATIVE DISORDER |
8 |
0.0027 |
| 438 |
OTOTOXICITY |
5 |
0.0027 |
| 439 |
ILEUS PARALYTIC |
12 |
0.0027 |
| 440 |
HEPATIC FAILURE |
81 |
0.0027 |
| 441 |
MALNUTRITION |
30 |
0.0027 |
| 442 |
ASPARTATE AMINOTRANSFERASE INCREASED |
142 |
0.0027 |
| 443 |
OESOPHAGITIS |
29 |
0.0027 |
| 444 |
PNEUMOTHORAX |
42 |
0.0026 |
| 445 |
PROCTALGIA |
17 |
0.0026 |
| 446 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
23 |
0.0026 |
| 447 |
LUNG INFECTION |
41 |
0.0026 |
| 448 |
HYPERVOLAEMIA |
13 |
0.0026 |
| 449 |
LUNG INFILTRATION |
23 |
0.0026 |
| 450 |
LYMPHOCYTE COUNT DECREASED |
46 |
0.0026 |
| 451 |
VASCULITIS |
30 |
0.0026 |
| 452 |
PSYCHIATRIC SYMPTOM |
19 |
0.0026 |
| 453 |
HYPOPHOSPHATAEMIA |
19 |
0.0026 |
| 454 |
ENCEPHALOPATHY |
63 |
0.0026 |
| 455 |
BLOOD PHOSPHORUS INCREASED |
7 |
0.0026 |
| 456 |
NECROTISING FASCIITIS |
9 |
0.0026 |
| 457 |
SUBARACHNOID HAEMORRHAGE |
26 |
0.0026 |
| 458 |
CARDIAC FAILURE ACUTE |
17 |
0.0025 |
| 459 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
140 |
0.0025 |
| 460 |
LACUNAR INFARCTION |
6 |
0.0025 |
| 461 |
STUPOR |
8 |
0.0025 |
| 462 |
PERICARDIAL EFFUSION |
56 |
0.0024 |
| 463 |
INFLAMMATORY MARKER INCREASED |
12 |
0.0024 |
| 464 |
STEM CELL TRANSPLANT |
6 |
0.0024 |
| 465 |
NEUROTOXICITY |
42 |
0.0024 |
| 466 |
ALANINE AMINOTRANSFERASE INCREASED |
147 |
0.0024 |
| 467 |
NEUTROPENIA |
322 |
0.0024 |
| 468 |
BONE MARROW FAILURE |
48 |
0.0024 |
| 469 |
HEPATIC CYST |
8 |
0.0024 |
| 470 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
37 |
0.0023 |
| 471 |
CACHEXIA |
12 |
0.0023 |
| 472 |
DRUG ERUPTION |
41 |
0.0023 |
| 473 |
FAILURE TO THRIVE |
12 |
0.0023 |
| 474 |
NOSOCOMIAL INFECTION |
5 |
0.0023 |
| 475 |
ATRIAL FLUTTER |
18 |
0.0023 |
| 476 |
RENAL IMPAIRMENT |
189 |
0.0022 |
| 477 |
HEPATOTOXICITY |
50 |
0.0022 |
| 478 |
BLOOD SODIUM INCREASED |
6 |
0.0022 |
| 479 |
HYPERTRIGLYCERIDAEMIA |
13 |
0.0022 |
| 480 |
DIFFUSE LARGE B-CELL LYMPHOMA |
17 |
0.0022 |
| 481 |
COMPLICATIONS OF TRANSPLANTED KIDNEY |
5 |
0.0022 |
| 482 |
HYPERLIPIDAEMIA |
26 |
0.0022 |
| 483 |
PROTHROMBIN TIME PROLONGED |
13 |
0.0022 |
| 484 |
TOXIC ENCEPHALOPATHY |
11 |
0.0022 |
| 485 |
RED CELL DISTRIBUTION WIDTH INCREASED |
9 |
0.0022 |
| 486 |
METHAEMOGLOBINAEMIA |
5 |
0.0022 |
| 487 |
METABOLIC ACIDOSIS |
69 |
0.0022 |
| 488 |
STREPTOCOCCAL INFECTION |
12 |
0.0022 |
| 489 |
LEUKOCYTOSIS |
39 |
0.0022 |
| 490 |
RENAL TUBULAR NECROSIS |
21 |
0.0021 |
| 491 |
RESPIRATORY DISTRESS |
59 |
0.0021 |
| 492 |
DRUG-INDUCED LIVER INJURY |
67 |
0.0021 |
| 493 |
PROTEIN TOTAL DECREASED |
8 |
0.0021 |
| 494 |
NEUTROPENIC SEPSIS |
15 |
0.0021 |
| 495 |
AGRANULOCYTOSIS |
39 |
0.0021 |
| 496 |
MENINGITIS |
14 |
0.0021 |
| 497 |
PANCREATITIS ACUTE |
47 |
0.0021 |
| 498 |
HYPOVOLAEMIC SHOCK |
10 |
0.0021 |
| 499 |
LONG QT SYNDROME |
5 |
0.0021 |
| 500 |
ENTEROCOLITIS |
12 |
0.0021 |
| 501 |
PERITONITIS |
43 |
0.0021 |
| 502 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
51 |
0.0021 |
| 503 |
HEPARIN-INDUCED THROMBOCYTOPENIA |
10 |
0.0020 |
| 504 |
HYPERCALCAEMIA |
25 |
0.0020 |
| 505 |
ACUTE KIDNEY INJURY |
307 |
0.0020 |
| 506 |
LEUKOPENIA |
100 |
0.0020 |
| 507 |
FLUID OVERLOAD |
29 |
0.0020 |
| 508 |
LUNG TRANSPLANT |
7 |
0.0020 |
| 509 |
FIBRIN D DIMER INCREASED |
7 |
0.0020 |
| 510 |
NOCARDIOSIS |
5 |
0.0020 |
| 511 |
NEUTROPHIL COUNT INCREASED |
20 |
0.0020 |
| 512 |
HEPATOSPLENOMEGALY |
5 |
0.0019 |
| 513 |
LEFT VENTRICULAR DYSFUNCTION |
13 |
0.0019 |
| 514 |
EOSINOPHILIA |
34 |
0.0019 |
| 515 |
NEUTROPHIL COUNT DECREASED |
79 |
0.0019 |
| 516 |
VENTRICULAR TACHYCARDIA |
32 |
0.0019 |
| 517 |
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS |
15 |
0.0019 |
| 518 |
TRANSAMINASES INCREASED |
42 |
0.0019 |
| 519 |
FEBRILE BONE MARROW APLASIA |
8 |
0.0019 |
| 520 |
HYPOTHERMIA |
19 |
0.0019 |
| 521 |
ASCITES |
55 |
0.0019 |
| 522 |
BLOOD CALCIUM DECREASED |
21 |
0.0019 |
| 523 |
HAEMOPTYSIS |
52 |
0.0019 |
| 524 |
PORTAL VEIN THROMBOSIS |
6 |
0.0019 |
| 525 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
41 |
0.0018 |
| 526 |
DECUBITUS ULCER |
15 |
0.0018 |
| 527 |
CHOLESTASIS |
35 |
0.0018 |
| 528 |
CIRCULATORY COLLAPSE |
31 |
0.0018 |
| 529 |
PROTEIN URINE PRESENT |
9 |
0.0018 |
| 530 |
HYPERAMMONAEMIA |
9 |
0.0018 |
| 531 |
DERMATITIS BULLOUS |
13 |
0.0018 |
| 532 |
HYPOMAGNESAEMIA |
25 |
0.0018 |
| 533 |
CHOLANGITIS |
11 |
0.0018 |
| 534 |
CLOSTRIDIAL INFECTION |
6 |
0.0018 |
| 535 |
BLOOD PRESSURE SYSTOLIC DECREASED |
8 |
0.0018 |
| 536 |
OESOPHAGEAL CANDIDIASIS |
7 |
0.0018 |
| 537 |
ORAL CANDIDIASIS |
23 |
0.0017 |
| 538 |
C-REACTIVE PROTEIN INCREASED |
63 |
0.0017 |
| 539 |
HEMIPARESIS |
29 |
0.0017 |
| 540 |
RASH MACULO-PAPULAR |
38 |
0.0017 |
| 541 |
CEREBRAL HAEMORRHAGE |
61 |
0.0017 |
| 542 |
PAPULE |
12 |
0.0017 |
| 543 |
ABSCESS |
27 |
0.0017 |
| 544 |
CONJUNCTIVAL HYPERAEMIA |
6 |
0.0017 |
| 545 |
PYREXIA |
580 |
0.0017 |
| 546 |
SUBCUTANEOUS ABSCESS |
8 |
0.0017 |
| 547 |
LIVER DISORDER |
73 |
0.0016 |
| 548 |
MOUTH HAEMORRHAGE |
12 |
0.0016 |
| 549 |
THROMBOCYTOPENIA |
183 |
0.0016 |
| 550 |
DUODENITIS |
5 |
0.0016 |
| 551 |
SPLENOMEGALY |
19 |
0.0016 |
| 552 |
BRAIN DEATH |
5 |
0.0016 |
| 553 |
NECROSIS |
9 |
0.0016 |
| 554 |
ALTERED STATE OF CONSCIOUSNESS |
35 |
0.0016 |
| 555 |
INTERSTITIAL LUNG DISEASE |
78 |
0.0016 |
| 556 |
ACUTE HEPATIC FAILURE |
22 |
0.0016 |
| 557 |
HAEMORRHAGE INTRACRANIAL |
24 |
0.0016 |
| 558 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
27 |
0.0016 |
| 559 |
MELAENA |
35 |
0.0016 |
| 560 |
TOXIC SKIN ERUPTION |
16 |
0.0016 |
| 561 |
ELECTROCARDIOGRAM QT PROLONGED |
57 |
0.0016 |
| 562 |
SPINAL COMPRESSION FRACTURE |
13 |
0.0016 |
| 563 |
OESOPHAGEAL ULCER |
6 |
0.0016 |
| 564 |
CEREBRAL ISCHAEMIA |
8 |
0.0016 |
| 565 |
STRESS CARDIOMYOPATHY |
9 |
0.0015 |
| 566 |
HERPES SIMPLEX |
10 |
0.0015 |
| 567 |
DRUG LEVEL ABOVE THERAPEUTIC |
7 |
0.0015 |
| 568 |
MYELODYSPLASTIC SYNDROME |
22 |
0.0015 |
| 569 |
BLOOD LACTIC ACID INCREASED |
8 |
0.0015 |
| 570 |
POLYDIPSIA |
6 |
0.0015 |
| 571 |
CLOSTRIDIUM DIFFICILE INFECTION |
33 |
0.0015 |
| 572 |
DRUG LEVEL INCREASED |
25 |
0.0015 |
| 573 |
MENTAL STATUS CHANGES |
41 |
0.0015 |
| 574 |
PERIPHERAL ISCHAEMIA |
6 |
0.0015 |
| 575 |
SUPRAVENTRICULAR TACHYCARDIA |
14 |
0.0015 |
| 576 |
ARTHRITIS BACTERIAL |
6 |
0.0015 |
| 577 |
PRODUCT USE IN UNAPPROVED INDICATION |
362 |
0.0015 |
| 578 |
KIDNEY TRANSPLANT REJECTION |
7 |
0.0015 |
| 579 |
LACTIC ACIDOSIS |
47 |
0.0014 |
| 580 |
ILEUS |
18 |
0.0014 |
| 581 |
CEREBRAL INFARCTION |
35 |
0.0014 |
| 582 |
INCORRECT DOSAGE ADMINISTERED |
7 |
0.0014 |
| 583 |
RENAL FAILURE |
190 |
0.0014 |
| 584 |
HAEMOLYSIS |
11 |
0.0014 |
| 585 |
PRODUCT PRESCRIBING ISSUE |
31 |
0.0014 |
| 586 |
HAEMATOCRIT DECREASED |
28 |
0.0014 |
| 587 |
HAEMORRHAGIC DIATHESIS |
5 |
0.0014 |
| 588 |
HEPATIC ENZYME ABNORMAL |
7 |
0.0014 |
| 589 |
DISEASE PROGRESSION |
165 |
0.0014 |
| 590 |
METABOLIC DISORDER |
8 |
0.0014 |
| 591 |
DIVERTICULUM INTESTINAL |
6 |
0.0014 |
| 592 |
HYPERKALAEMIA |
48 |
0.0014 |
| 593 |
HYPOVOLAEMIA |
8 |
0.0014 |
| 594 |
IMMUNOSUPPRESSION |
12 |
0.0014 |
| 595 |
LIVER FUNCTION TEST INCREASED |
29 |
0.0013 |
| 596 |
CARDIAC DYSFUNCTION |
5 |
0.0013 |
| 597 |
LYMPHOPENIA |
19 |
0.0013 |
| 598 |
PLATELET COUNT DECREASED |
143 |
0.0013 |
| 599 |
TONSILLITIS |
7 |
0.0013 |
| 600 |
IRON DEFICIENCY |
6 |
0.0013 |
| 601 |
POSTOPERATIVE WOUND INFECTION |
9 |
0.0013 |
| 602 |
PNEUMONIA ASPIRATION |
33 |
0.0013 |
| 603 |
NEPHROTIC SYNDROME |
9 |
0.0013 |
| 604 |
CENTRAL NERVOUS SYSTEM LESION |
18 |
0.0013 |
| 605 |
UROSEPSIS |
12 |
0.0013 |
| 606 |
BRUXISM |
7 |
0.0013 |
| 607 |
LYMPHOMA |
20 |
0.0013 |
| 608 |
NEPHROPATHY |
12 |
0.0013 |
| 609 |
APPENDICITIS |
12 |
0.0013 |
| 610 |
FAECALOMA |
7 |
0.0013 |
| 611 |
PULMONARY TOXICITY |
9 |
0.0013 |
| 612 |
CARDIAC ARREST |
105 |
0.0013 |
| 613 |
INFECTION |
184 |
0.0013 |
| 614 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
13 |
0.0013 |
| 615 |
URINE OUTPUT DECREASED |
11 |
0.0013 |
| 616 |
BLOOD CREATININE INCREASED |
82 |
0.0013 |
| 617 |
CONTRAINDICATED PRODUCT ADMINISTERED |
38 |
0.0013 |
| 618 |
AZOTAEMIA |
5 |
0.0013 |
| 619 |
CREATININE RENAL CLEARANCE DECREASED |
5 |
0.0012 |
| 620 |
PNEUMONITIS |
34 |
0.0012 |
| 621 |
DRUG INTERACTION |
198 |
0.0012 |
| 622 |
ACUTE PULMONARY OEDEMA |
7 |
0.0012 |
| 623 |
BLOOD URIC ACID INCREASED |
7 |
0.0012 |
| 624 |
DELIRIUM |
42 |
0.0012 |
| 625 |
CORONAVIRUS INFECTION |
8 |
0.0012 |
| 626 |
ELECTROLYTE IMBALANCE |
14 |
0.0012 |
| 627 |
HYDRONEPHROSIS |
9 |
0.0012 |
| 628 |
UNRESPONSIVE TO STIMULI |
31 |
0.0012 |
| 629 |
DERMATITIS EXFOLIATIVE |
6 |
0.0012 |
| 630 |
PNEUMONIA |
388 |
0.0012 |
| 631 |
PERIPHERAL SENSORY NEUROPATHY |
7 |
0.0012 |
| 632 |
BRONCHIECTASIS |
8 |
0.0012 |
| 633 |
LIPASE INCREASED |
9 |
0.0012 |
| 634 |
TUBULOINTERSTITIAL NEPHRITIS |
22 |
0.0012 |
| 635 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
30 |
0.0012 |
| 636 |
COLITIS |
44 |
0.0012 |
| 637 |
THERAPY NON-RESPONDER |
52 |
0.0012 |
| 638 |
RENAL FAILURE ACUTE |
49 |
0.0012 |
| 639 |
HAEMORRHAGIC STROKE |
9 |
0.0012 |
| 640 |
MALABSORPTION |
6 |
0.0011 |
| 641 |
WHITE BLOOD CELL COUNT INCREASED |
44 |
0.0011 |
| 642 |
RIGHT VENTRICULAR FAILURE |
8 |
0.0011 |
| 643 |
CONCOMITANT DISEASE AGGRAVATED |
7 |
0.0011 |
| 644 |
DRUG INEFFECTIVE |
1486 |
0.0011 |
| 645 |
HEPATOMEGALY |
11 |
0.0011 |
| 646 |
ANAL ABSCESS |
6 |
0.0011 |
| 647 |
TREATMENT FAILURE |
92 |
0.0011 |
| 648 |
ENTERITIS |
7 |
0.0011 |
| 649 |
NERVOUS SYSTEM DISORDER |
34 |
0.0011 |
| 650 |
STOMATITIS |
66 |
0.0011 |
| 651 |
LOWER GASTROINTESTINAL HAEMORRHAGE |
8 |
0.0011 |
| 652 |
CELLULITIS |
54 |
0.0011 |
| 653 |
ADRENAL INSUFFICIENCY |
13 |
0.0011 |
| 654 |
INTESTINAL PERFORATION |
12 |
0.0011 |
| 655 |
CHOLECYSTITIS ACUTE |
6 |
0.0011 |
| 656 |
HYPOCALCAEMIA |
20 |
0.0011 |
| 657 |
SMALL INTESTINAL OBSTRUCTION |
13 |
0.0011 |
| 658 |
PETECHIAE |
11 |
0.0011 |
| 659 |
WHITE BLOOD CELL COUNT DECREASED |
114 |
0.0011 |
| 660 |
SKIN MASS |
7 |
0.0010 |
| 661 |
HYPONATRAEMIA |
59 |
0.0010 |
| 662 |
OFF LABEL USE |
902 |
0.0010 |
| 663 |
LIVER INJURY |
25 |
0.0010 |
| 664 |
GASTROINTESTINAL HAEMORRHAGE |
85 |
0.0010 |
| 665 |
CARDIOTOXICITY |
9 |
0.0010 |
| 666 |
ANAEMIA |
192 |
0.0010 |
| 667 |
ENDOPHTHALMITIS |
6 |
0.0010 |
| 668 |
HYPOTENSION |
200 |
0.0010 |
| 669 |
MIOSIS |
8 |
0.0010 |
| 670 |
HEPATITIS CHOLESTATIC |
6 |
0.0010 |
| 671 |
VENTRICULAR FIBRILLATION |
11 |
0.0010 |
| 672 |
DYSPHORIA |
5 |
0.0010 |
| 673 |
PULMONARY OEDEMA |
44 |
0.0010 |
| 674 |
SUBDURAL HAEMATOMA |
14 |
0.0010 |
| 675 |
HYPOPHAGIA |
25 |
0.0010 |
| 676 |
POLYURIA |
8 |
0.0010 |
| 677 |
ATRIAL FIBRILLATION |
94 |
0.0010 |
| 678 |
RASH PUSTULAR |
7 |
0.0010 |
| 679 |
RESPIRATORY TRACT INFECTION |
25 |
0.0010 |
| 680 |
MYOCARDITIS |
11 |
0.0010 |
| 681 |
OSTEOMYELITIS |
17 |
0.0009 |
| 682 |
HYPERGLYCAEMIA |
34 |
0.0009 |
| 683 |
BLOOD MAGNESIUM DECREASED |
8 |
0.0009 |
| 684 |
INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS |
5 |
0.0009 |
| 685 |
PULMONARY CONGESTION |
12 |
0.0009 |
| 686 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
36 |
0.0009 |
| 687 |
PANCREATITIS |
48 |
0.0009 |
| 688 |
CARDIOGENIC SHOCK |
13 |
0.0009 |
| 689 |
CYSTIC FIBROSIS |
5 |
0.0009 |
| 690 |
HALLUCINATION, VISUAL |
19 |
0.0009 |
| 691 |
HEPATIC ENZYME INCREASED |
61 |
0.0009 |
| 692 |
HAEMOLYTIC ANAEMIA |
8 |
0.0009 |
| 693 |
CYANOSIS |
14 |
0.0009 |
| 694 |
CARDIOMYOPATHY |
13 |
0.0009 |
| 695 |
NEUTROPHILIA |
5 |
0.0009 |
| 696 |
ECCHYMOSIS |
6 |
0.0009 |
| 697 |
ORAL HERPES |
17 |
0.0009 |
| 698 |
RESPIRATORY DISORDER |
26 |
0.0009 |
| 699 |
HERPES VIRUS INFECTION |
5 |
0.0009 |
| 700 |
TACHYCARDIA |
77 |
0.0009 |
| 701 |
HYPOGLYCAEMIA |
42 |
0.0009 |
| 702 |
BLOOD POTASSIUM INCREASED |
14 |
0.0009 |
| 703 |
LIVER FUNCTION TEST ABNORMAL |
25 |
0.0009 |
| 704 |
CARDIAC FAILURE |
69 |
0.0009 |
| 705 |
ABNORMAL FAECES |
7 |
0.0009 |
| 706 |
OXYGEN SATURATION DECREASED |
48 |
0.0009 |
| 707 |
HICCUPS |
7 |
0.0009 |
| 708 |
CYSTITIS |
27 |
0.0008 |
| 709 |
DIALYSIS |
12 |
0.0008 |
| 710 |
CONDITION AGGRAVATED |
257 |
0.0008 |
| 711 |
PLATELET COUNT INCREASED |
11 |
0.0008 |
| 712 |
EOSINOPHIL COUNT INCREASED |
7 |
0.0008 |
| 713 |
HAEMATEMESIS |
21 |
0.0008 |
| 714 |
ASPIRATION |
9 |
0.0008 |
| 715 |
FACIAL PARALYSIS |
7 |
0.0008 |
| 716 |
HAEMATURIA |
28 |
0.0008 |
| 717 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
19 |
0.0008 |
| 718 |
BLOOD POTASSIUM DECREASED |
24 |
0.0008 |
| 719 |
APHASIA |
24 |
0.0008 |
| 720 |
RESPIRATORY RATE INCREASED |
7 |
0.0008 |
| 721 |
GENERALISED TONIC-CLONIC SEIZURE |
13 |
0.0008 |
| 722 |
JAUNDICE |
21 |
0.0008 |
| 723 |
SINUS TACHYCARDIA |
11 |
0.0008 |
| 724 |
RASH ERYTHEMATOUS |
37 |
0.0008 |
| 725 |
RED BLOOD CELL COUNT DECREASED |
22 |
0.0008 |
| 726 |
HAEMOGLOBIN DECREASED |
79 |
0.0008 |
| 727 |
HEPATITIS ACUTE |
5 |
0.0008 |
| 728 |
PARALYSIS |
11 |
0.0008 |
| 729 |
GASTROINTESTINAL INFLAMMATION |
6 |
0.0008 |
| 730 |
LYMPHADENOPATHY |
27 |
0.0008 |
| 731 |
IRON DEFICIENCY ANAEMIA |
7 |
0.0008 |
| 732 |
RENAL CYST |
6 |
0.0008 |
| 733 |
HERPES ZOSTER |
43 |
0.0007 |
| 734 |
BODY TEMPERATURE INCREASED |
15 |
0.0007 |
| 735 |
SKIN LESION |
20 |
0.0007 |
| 736 |
HEMIPLEGIA |
6 |
0.0007 |
| 737 |
PULMONARY HYPERTENSION |
15 |
0.0007 |
| 738 |
EPILEPSY |
22 |
0.0007 |
| 739 |
OEDEMA |
39 |
0.0007 |
| 740 |
RENAL DISORDER |
33 |
0.0007 |
| 741 |
EJECTION FRACTION DECREASED |
11 |
0.0007 |
| 742 |
BRAIN INJURY |
7 |
0.0007 |
| 743 |
DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
5 |
0.0007 |
| 744 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
20 |
0.0007 |
| 745 |
DISEASE RECURRENCE |
33 |
0.0007 |
| 746 |
GENERAL PHYSICAL HEALTH DETERIORATION |
80 |
0.0007 |
| 747 |
LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR |
6 |
0.0007 |
| 748 |
VENTRICULAR EXTRASYSTOLES |
7 |
0.0007 |
| 749 |
MYOSITIS |
6 |
0.0007 |
| 750 |
BLOOD PRESSURE FLUCTUATION |
16 |
0.0007 |
| 751 |
HEPATITIS |
17 |
0.0007 |
| 752 |
INCONTINENCE |
7 |
0.0007 |
| 753 |
RESPIRATORY ARREST |
18 |
0.0007 |
| 754 |
OVARIAN CANCER |
6 |
0.0007 |
| 755 |
CARDIOMEGALY |
8 |
0.0006 |
| 756 |
GASTRITIS |
17 |
0.0006 |
| 757 |
CARDIO-RESPIRATORY ARREST |
27 |
0.0006 |
| 758 |
INTERVERTEBRAL DISC PROTRUSION |
14 |
0.0006 |
| 759 |
HEPATOCELLULAR INJURY |
9 |
0.0006 |
| 760 |
BLOOD PRESSURE DECREASED |
42 |
0.0006 |
| 761 |
COMA |
30 |
0.0006 |
| 762 |
OBSTRUCTIVE AIRWAYS DISORDER |
7 |
0.0006 |
| 763 |
EMBOLISM |
5 |
0.0006 |
| 764 |
HAEMODIALYSIS |
5 |
0.0006 |
| 765 |
CHOLECYSTITIS |
7 |
0.0006 |
| 766 |
MYOPATHY |
5 |
0.0006 |
| 767 |
THERAPY PARTIAL RESPONDER |
9 |
0.0006 |
| 768 |
NO THERAPEUTIC RESPONSE |
7 |
0.0006 |
| 769 |
GLOMERULAR FILTRATION RATE DECREASED |
7 |
0.0006 |
| 770 |
MOUTH ULCERATION |
12 |
0.0006 |
| 771 |
ABDOMINAL PAIN |
132 |
0.0006 |
| 772 |
HALLUCINATION, AUDITORY |
9 |
0.0006 |
| 773 |
BRADYCARDIA |
30 |
0.0006 |
| 774 |
PLASMA CELL MYELOMA |
22 |
0.0006 |
| 775 |
ISCHAEMIC STROKE |
10 |
0.0006 |
| 776 |
INFUSION RELATED REACTION |
37 |
0.0006 |
| 777 |
COMPLICATION ASSOCIATED WITH DEVICE |
8 |
0.0006 |
| 778 |
ARRHYTHMIA |
26 |
0.0005 |
| 779 |
END STAGE RENAL DISEASE |
10 |
0.0005 |
| 780 |
IMPAIRED HEALING |
18 |
0.0005 |
| 781 |
HAEMATOCHEZIA |
30 |
0.0005 |
| 782 |
IMMUNODEFICIENCY |
8 |
0.0005 |
| 783 |
FACE OEDEMA |
9 |
0.0005 |
| 784 |
STATUS EPILEPTICUS |
6 |
0.0005 |
| 785 |
DERMATITIS CONTACT |
6 |
0.0005 |
| 786 |
PRODUCTIVE COUGH |
25 |
0.0005 |
| 787 |
HYPERTENSION |
110 |
0.0005 |
| 788 |
UVEITIS |
7 |
0.0005 |
| 789 |
URINARY RETENTION |
17 |
0.0005 |
| 790 |
ATAXIA |
6 |
0.0005 |
| 791 |
MYOCLONUS |
6 |
0.0005 |
| 792 |
POLYNEUROPATHY |
6 |
0.0005 |
| 793 |
PRESYNCOPE |
12 |
0.0005 |
| 794 |
SEIZURE |
57 |
0.0005 |
| 795 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
35 |
0.0005 |
| 796 |
BRONCHOSPASM |
7 |
0.0005 |
| 797 |
LUNG DISORDER |
24 |
0.0005 |
| 798 |
GASTROENTERITIS |
7 |
0.0005 |
| 799 |
RHABDOMYOLYSIS |
20 |
0.0005 |
| 800 |
PALLOR |
13 |
0.0005 |
| 801 |
BLOOD SODIUM DECREASED |
9 |
0.0005 |
| 802 |
UPPER RESPIRATORY TRACT INFECTION |
22 |
0.0005 |
| 803 |
DIARRHOEA |
300 |
0.0005 |
| 804 |
HIATUS HERNIA |
6 |
0.0005 |
| 805 |
INTERNATIONAL NORMALISED RATIO INCREASED |
13 |
0.0005 |
| 806 |
FLUID RETENTION |
23 |
0.0005 |
| 807 |
HAEMORRHAGE |
47 |
0.0004 |
| 808 |
ORAL PAIN |
10 |
0.0004 |
| 809 |
DEEP VEIN THROMBOSIS |
29 |
0.0004 |
| 810 |
CHROMATURIA |
10 |
0.0004 |
| 811 |
ACUTE MYOCARDIAL INFARCTION |
13 |
0.0004 |
| 812 |
DRUG TOXICITY |
6 |
0.0004 |
| 813 |
MYOCARDIAL ISCHAEMIA |
5 |
0.0004 |
| 814 |
RESTLESSNESS |
16 |
0.0004 |
| 815 |
GASTRIC HAEMORRHAGE |
5 |
0.0004 |
| 816 |
NEOPLASM PROGRESSION |
15 |
0.0004 |
| 817 |
COORDINATION ABNORMAL |
6 |
0.0004 |
| 818 |
ANAPHYLACTIC SHOCK |
11 |
0.0004 |
| 819 |
SKIN ULCER |
11 |
0.0004 |
| 820 |
GLAUCOMA |
8 |
0.0004 |
| 821 |
EPISTAXIS |
31 |
0.0004 |
| 822 |
NOCTURIA |
5 |
0.0004 |
| 823 |
RENAL INJURY |
12 |
0.0004 |
| 824 |
ABDOMINAL DISTENSION |
42 |
0.0004 |
| 825 |
MALIGNANT NEOPLASM PROGRESSION |
41 |
0.0004 |
| 826 |
VIRAL INFECTION |
13 |
0.0004 |
| 827 |
INTENTIONAL PRODUCT USE ISSUE |
34 |
0.0004 |
| 828 |
INFLAMMATION |
20 |
0.0004 |
| 829 |
HAEMATOMA |
10 |
0.0004 |
| 830 |
PRODUCT USE ISSUE |
72 |
0.0004 |
| 831 |
DERMATITIS |
8 |
0.0004 |
| 832 |
ANAPHYLACTIC REACTION |
21 |
0.0004 |
| 833 |
IMMUNE SYSTEM DISORDER |
5 |
0.0004 |
| 834 |
PULMONARY EMBOLISM |
36 |
0.0004 |
| 835 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
11 |
0.0004 |
| 836 |
LABORATORY TEST ABNORMAL |
11 |
0.0004 |
| 837 |
HEPATIC CIRRHOSIS |
7 |
0.0004 |
| 838 |
SINUSITIS |
38 |
0.0004 |
| 839 |
COVID-19 |
65 |
0.0004 |
| 840 |
FAECES DISCOLOURED |
8 |
0.0004 |
| 841 |
CHILLS |
43 |
0.0004 |
| 842 |
IMPAIRED GASTRIC EMPTYING |
5 |
0.0004 |
| 843 |
PHOTOSENSITIVITY REACTION |
6 |
0.0004 |
| 844 |
THERAPEUTIC RESPONSE DECREASED |
22 |
0.0004 |
| 845 |
EXTRAPYRAMIDAL DISORDER |
9 |
0.0004 |
| 846 |
PRESCRIBED OVERDOSE |
7 |
0.0004 |
| 847 |
PERICARDITIS |
6 |
0.0004 |
| 848 |
TOXICITY TO VARIOUS AGENTS |
60 |
0.0004 |
| 849 |
VOMITING |
167 |
0.0004 |
| 850 |
URINARY TRACT INFECTION |
60 |
0.0004 |
| 851 |
RECTAL HAEMORRHAGE |
15 |
0.0003 |
| 852 |
BLOOD TRIGLYCERIDES INCREASED |
6 |
0.0003 |
| 853 |
INFLUENZA |
37 |
0.0003 |
| 854 |
DIVERTICULITIS |
9 |
0.0003 |
| 855 |
HEPATIC STEATOSIS |
6 |
0.0003 |
| 856 |
OEDEMA PERIPHERAL |
39 |
0.0003 |
| 857 |
DYSPNOEA EXERTIONAL |
12 |
0.0003 |
| 858 |
DYSPNOEA |
179 |
0.0003 |
| 859 |
GASTRIC ULCER |
6 |
0.0003 |
| 860 |
PROTEINURIA |
6 |
0.0003 |
| 861 |
CONVULSION |
18 |
0.0003 |
| 862 |
HYPOTHYROIDISM |
10 |
0.0003 |
| 863 |
POST PROCEDURAL COMPLICATION |
6 |
0.0003 |
| 864 |
CONFUSIONAL STATE |
50 |
0.0003 |
| 865 |
DEAFNESS |
8 |
0.0003 |
| 866 |
RASH |
132 |
0.0003 |
| 867 |
DYSURIA |
11 |
0.0003 |
| 868 |
FULL BLOOD COUNT DECREASED |
6 |
0.0003 |
| 869 |
LETHARGY |
17 |
0.0003 |
| 870 |
THROMBOSIS |
23 |
0.0003 |
| 871 |
DEATH |
246 |
0.0003 |
| 872 |
AMENORRHOEA |
5 |
0.0003 |
| 873 |
BRONCHITIS |
21 |
0.0003 |
| 874 |
COUGH |
78 |
0.0003 |
| 875 |
CHRONIC KIDNEY DISEASE |
21 |
0.0003 |
| 876 |
CONSTIPATION |
60 |
0.0003 |
| 877 |
BONE PAIN |
16 |
0.0003 |
| 878 |
DYSKINESIA |
11 |
0.0003 |
| 879 |
BLISTER |
15 |
0.0003 |
| 880 |
DYSARTHRIA |
10 |
0.0003 |
| 881 |
GASTROINTESTINAL DISORDER |
23 |
0.0003 |
| 882 |
DEHYDRATION |
34 |
0.0003 |
| 883 |
DISORIENTATION |
10 |
0.0003 |
| 884 |
PROCEDURAL PAIN |
7 |
0.0003 |
| 885 |
NEUROPATHY PERIPHERAL |
24 |
0.0003 |
| 886 |
BLOOD PRESSURE ABNORMAL |
5 |
0.0003 |
| 887 |
LOSS OF CONSCIOUSNESS |
32 |
0.0002 |
| 888 |
DECREASED APPETITE |
58 |
0.0002 |
| 889 |
OROPHARYNGEAL PAIN |
22 |
0.0002 |
| 890 |
NAUSEA |
188 |
0.0002 |
| 891 |
TRANSIENT ISCHAEMIC ATTACK |
8 |
0.0002 |
| 892 |
EATING DISORDER |
5 |
0.0002 |
| 893 |
LACRIMATION INCREASED |
7 |
0.0002 |
| 894 |
ERYTHEMA |
47 |
0.0002 |
| 895 |
SWELLING |
21 |
0.0002 |
| 896 |
HEART RATE IRREGULAR |
5 |
0.0002 |
| 897 |
NO ADVERSE EVENT |
40 |
0.0002 |
| 898 |
CHOLELITHIASIS |
7 |
0.0002 |
| 899 |
SKIN EXFOLIATION |
18 |
0.0002 |
| 900 |
BLOOD GLUCOSE INCREASED |
40 |
0.0002 |
| 901 |
PAIN IN JAW |
6 |
0.0002 |
| 902 |
MENTAL DISORDER |
9 |
0.0002 |
| 903 |
TREMOR |
34 |
0.0002 |
| 904 |
PREMATURE BABY |
6 |
0.0002 |
| 905 |
CARDIAC FAILURE CONGESTIVE |
16 |
0.0002 |
| 906 |
ILL-DEFINED DISORDER |
12 |
0.0002 |
| 907 |
PALPITATIONS |
23 |
0.0002 |
| 908 |
CHEST DISCOMFORT |
20 |
0.0002 |
| 909 |
INSOMNIA |
51 |
0.0002 |
| 910 |
MATERNAL EXPOSURE DURING PREGNANCY |
17 |
0.0002 |
| 911 |
WEIGHT DECREASED |
53 |
0.0002 |
| 912 |
RASH PRURITIC |
10 |
0.0002 |
| 913 |
ADVERSE EVENT |
17 |
0.0002 |
| 914 |
SYNCOPE |
18 |
0.0002 |
| 915 |
SKIN DISORDER |
6 |
0.0002 |
| 916 |
DYSPHAGIA |
17 |
0.0002 |
| 917 |
SOMNOLENCE |
36 |
0.0002 |
| 918 |
CHEST PAIN |
33 |
0.0002 |
| 919 |
UNDERDOSE |
13 |
0.0002 |
| 920 |
AGITATION |
13 |
0.0002 |
| 921 |
BACK PAIN |
40 |
0.0002 |
| 922 |
DIABETES MELLITUS |
13 |
0.0002 |
| 923 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
6 |
0.0002 |
| 924 |
DRUG INTOLERANCE |
16 |
0.0002 |
| 925 |
BALANCE DISORDER |
14 |
0.0002 |
| 926 |
GASTROOESOPHAGEAL REFLUX DISEASE |
13 |
0.0002 |
| 927 |
VISUAL IMPAIRMENT |
20 |
0.0002 |
| 928 |
HALLUCINATION |
12 |
0.0002 |
| 929 |
INTESTINAL OBSTRUCTION |
6 |
0.0002 |
| 930 |
RHINORRHOEA |
10 |
0.0002 |
| 931 |
VISION BLURRED |
21 |
0.0002 |
| 932 |
MUSCULAR WEAKNESS |
17 |
0.0001 |
| 933 |
ASTHENIA |
55 |
0.0001 |
| 934 |
WEIGHT INCREASED |
32 |
0.0001 |
| 935 |
ARTHRITIS |
11 |
0.0001 |
| 936 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
25 |
0.0001 |
| 937 |
SWELLING FACE |
9 |
0.0001 |
| 938 |
INTENTIONAL PRODUCT MISUSE |
12 |
0.0001 |
| 939 |
ABDOMINAL PAIN UPPER |
28 |
0.0001 |
| 940 |
HEADACHE |
83 |
0.0001 |
| 941 |
SKIN DISCOLOURATION |
6 |
0.0001 |
| 942 |
TREATMENT NONCOMPLIANCE |
7 |
0.0001 |
| 943 |
BLINDNESS |
5 |
0.0001 |
| 944 |
OVERDOSE |
26 |
0.0001 |
| 945 |
HYPERHIDROSIS |
15 |
0.0001 |
| 946 |
SPEECH DISORDER |
6 |
0.0001 |
| 947 |
HYPOAESTHESIA |
17 |
0.0001 |
| 948 |
ANGIOEDEMA |
5 |
0.0001 |
| 949 |
MYALGIA |
19 |
0.0001 |
| 950 |
BLOOD PRESSURE INCREASED |
17 |
0.0001 |
| 951 |
PAIN IN EXTREMITY |
31 |
0.0001 |
| 952 |
DYSPHONIA |
6 |
0.0001 |
| 953 |
FALL |
34 |
0.0001 |
| 954 |
PRURITUS |
39 |
0.0001 |
| 955 |
CATARACT |
6 |
0.0001 |
| 956 |
CEREBROVASCULAR ACCIDENT |
17 |
0.0001 |
| 957 |
DRY EYE |
5 |
0.0001 |
| 958 |
SLEEP DISORDER |
7 |
0.0001 |
| 959 |
HOSPITALISATION |
15 |
0.0001 |
| 960 |
MOBILITY DECREASED |
7 |
0.0001 |
| 961 |
HYPERSENSITIVITY |
18 |
0.0001 |
| 962 |
EXPOSURE DURING PREGNANCY |
6 |
0.0001 |
| 963 |
MUSCULOSKELETAL PAIN |
5 |
0.0001 |
| 964 |
PAIN |
57 |
0.0001 |
| 965 |
MALAISE |
40 |
0.0001 |
| 966 |
FATIGUE |
71 |
0.0001 |
| 967 |
HEART RATE INCREASED |
9 |
0.0001 |
| 968 |
URTICARIA |
15 |
0.0001 |
| 969 |
NECK PAIN |
5 |
0.0001 |
| 970 |
EYE PAIN |
5 |
0.0001 |
| 971 |
ILLNESS |
9 |
0.0001 |
| 972 |
CARDIAC DISORDER |
8 |
0.0001 |
| 973 |
ABDOMINAL DISCOMFORT |
14 |
0.0001 |
| 974 |
GAIT DISTURBANCE |
15 |
0.0001 |
| 975 |
FOETAL EXPOSURE DURING PREGNANCY |
6 |
0.0001 |
| 976 |
INFLUENZA LIKE ILLNESS |
6 |
0.0001 |
| 977 |
DIZZINESS |
36 |
0.0001 |
| 978 |
PARAESTHESIA |
11 |
0.0001 |
| 979 |
ACCIDENTAL EXPOSURE TO PRODUCT |
7 |
0.0001 |
| 980 |
MUSCLE SPASMS |
12 |
0.0001 |
| 981 |
PERIPHERAL SWELLING |
10 |
0.0001 |
| 982 |
ANXIETY |
18 |
0.0001 |
| 983 |
ARTHRALGIA |
26 |
0.0001 |
| 984 |
CONTUSION |
6 |
0.0001 |
| 985 |
ALOPECIA |
11 |
0.0001 |
| 986 |
ASTHMA |
6 |
0.0001 |
| 987 |
MYOCARDIAL INFARCTION |
9 |
0.0001 |
| 988 |
PRODUCT DOSE OMISSION ISSUE |
15 |
0.0001 |
| 989 |
DYSPEPSIA |
5 |
0.0001 |
| 990 |
NASOPHARYNGITIS |
9 |
0.0000 |
| 991 |
DEPRESSION |
10 |
0.0000 |
| 992 |
INCORRECT DOSE ADMINISTERED |
9 |
0.0000 |
| 993 |
MEMORY IMPAIRMENT |
5 |
0.0000 |
| 994 |
DRUG DOSE OMISSION |
5 |
0.0000 |